Bristol Myers Squibb warns UK drug tax threatens investment

Bristol Myers Squibb warns UK drug tax threatens investment

Bristol chief executive Myers Squibb has warned that the US pharmaceutical company could divert investment from the UK due to the expansion of a tax meant to cap the NHS drug bill. Giovanni Caforio also said the low prices of medicines bought by the NHS from pharmaceutical companies was a major problem which threatened the …

Bristol Myers Squibb warns UK drug tax threatens investment Read More »